top of page
Particle Engineering Technology

At GBR Laboratories Pvt Ltd, we have a dedicated team of experts with tremendous experience in API drug Manufacturing and particle engineering. Our team can provide solutions to complex formulation challenges and rapidly progress novel drugs to market. Our advanced particle engineering technology can produce Nano size particles small (10nm) enough to cross biological barriers and even penetrate into the deep lung and large enough for nasal delivery (10 microns). This technology can be vastly used to cure Respiratory/ Pulmonary Diseases.

Image by Robina Weermeijer


Our particle engineering technology can we used on any API to reduce the particle size to 10nm, without the need for excipients. Our primary therapeutic focus has been:
   • Pulmonary hypertension/Fibrosis/Sarcoidosis
   • Anti-Bacterial
   • Anti-Biotic (Gram Positive and Gram Negative
   • Antivirals
   • Anti-Fungal
   • Oncology
   • COPD
   • Corticosteroids

We are confident that we can use this technology on other therapeutic area drugs or API's .
Our process enables precise control of particle size and shape, leading to highly stable APIs, with particle size as small and uniform as 10nm. The reduced particle size enables us to achieve TARGETED THERAPY, through lower & safer dosage, lowers the risk of side effects and higher efficacy.

Our advanced technology combined with our expertise allows us to deliver best-in-class API particle engineering services and optimized formulation solutions for our pharma partners.

Customer Services

We take our partners all the way through the process of drug development, from initial evaluation to proof of concept and process and finally to large-scale manufacture. 

Develop the products from “Ideation” Stage till “Proof-of-Concept” Stage.

Stage 1


(Initial Evaluation

Stage 2

Proof of concept and process

Stage 3

Scalability and stability assessment of the API

Image by CDC

Pulmonary Delivery

Our particle engineering technology enables the creation of nanoparticles small enough to penetrate into the deep lung. This opens up a new avenue of treatment for respiratory/Pulmonary disorders by using particle engineering on inhalation drugs, for targeted therapy drug delivery system.

bottom of page